OSF Healthcare launches its version of “Shark Tank”
At an event styled after the TV show but kinder and gentler, OSF HealthCare employees get 15 minutes to pitch their ideas to subject matter […]
At an event styled after the TV show but kinder and gentler, OSF HealthCare employees get 15 minutes to pitch their ideas to subject matter […]
Shots: Bio-Thera to receive $20M up front and $130M as development and commercial milestones and will be responsible for the development, manufacturing, and supply of […]
Called the Innovator Community Expansion Initiative, the main goal of the effort is to pinpoint and remove obstacles keeping underrepresented groups, like women, out of […]
Shots: CRISPR to receive $900M up front with an additional $200M milestone upon the regulatory approval of CTX001. Vertex will responsible for the global development, […]
Shots: Cullinan will receive $20M up front and is eligible to receive ~$211M in development, regulatory and sales-based milestone payments Cullinan is also eligible for […]
Shots: Following the FDA Type A meeting, Gilead will not pursue the approval of Jyseleca for RA in the US. Galapagos will be solely responsible […]
Shots: Relay to receive $75M as upfront, $25M in additional near-term payments, and has the right to opt for 50/50 profit/cost-sharing on RLY-1971 in the […]
Shots: The agreement strengthens the ongoing collaboration b/w the companies signed in 2018 to commercialize Alvotech’s biosimilar portfolio in Japan Fuji Pharma currently owns a […]
Shots: Chugai get an exclusive development and commercialization agreement in Japan for Roche’s Ab cocktail of casirivimab and imdevimab to combat COVID-19 Earlier, Roche & […]
Shots: KaliVir to receive $56M as upfront & other payments supporting the research & preclinical activities of VET2-L2 & is eligible to receive $307M & […]
Copyright © 2024 | WordPress Theme by MH Themes